PeerVoice Clinical Pharmacology Audio
Erwan Donal, MD, PhD / Nina Ajmone Marsan, MD, PhD - At the Cutting Edge of ATTR-CM: How Can We Leverage Advances in Multimodality Cardiac Imaging and Artificial Intelligence to Modernise Diagnosis and Monitoring?
Visit https://www.peervoice.com/EPK860 to view the entire programme with slides. After completing “Erwan Donal, MD, PhD / Nina Ajmone Marsan, MD, PhD - At the Cutting Edge of ATTR-CM: How Can We Leverage Advances in Multimodality Cardiac Imaging and Artificial Intelligence to Modernise Diagnosis and Monitoring?”, participants will be able to: Evaluate the strengths and limitations of multimodality cardiac imaging within the evolving diagnostic landscape of transthyretin amyloid cardiomyopathy (ATTR-CM); Assess the role and applications for multimodality cardiac imaging in monitoring treatment efficacy and disease progression in ATTR-CM; and Identify current and potential future applications of artificial intelligence in multimodality imaging in ATTR-CM.